Cargando…

Bendamustine/rituximab: COVID-19 pneumonia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233601/ http://dx.doi.org/10.1007/s40278-021-97872-7

Ejemplares similares

Bendamustine/dexamethasone/rituximab: Cytomegalovirus reactivation : case report
Publicado: (2021)

Bendamustine/rituximab: Neutropenia, fever and inflammation: case report
Publicado: (2022)

Paraneoplastic acute fibrinous and organizing pneumonia from lymphoma completely responding to bendamustine‐rituximab
por: Crowhurst, Thomas, et al.
Publicado: (2020)

Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022)

Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report
Publicado: (2022)

Painful, plantar nodules in cutaneous macroglobulinosis: Successful treatment with rituximab and bendamustine
por: D'Acunto, Carmine, et al.
Publicado: (2020)

Large B - Cell Lymphoma of the Leg – Unfavourable Course with Rituximab/Bendamustin
por: Wollina, Uwe, et al.
Publicado: (2019)

Prednisone/rituximab: COVID-19 pneumonia: case report
Publicado: (2021)

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy
por: Kamegai, Kohei, et al.
Publicado: (2022)

Two rare cases of bronchus‐associated lymphoid tissue lymphoma successfully treated with rituximab‐bendamustine
por: Panitz, Nydia, et al.
Publicado: (2021)

Immunosuppressants/rituximab: COVID-19-pneumonia: 2 case reports
Publicado: (2021)

Rituximab: Persistent COVID-19 pneumonia: 5 case reports
Publicado: (2022)

Bendamustine/obinutuzumab: COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report
Publicado: (2021)

Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases
por: Visentin, Andrea, et al.
Publicado: (2017)

B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases
por: Wang, Anna, et al.
Publicado: (2023)

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report
por: Monteiro, Rowan, et al.
Publicado: (2017)

An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review
por: Liao, Sih-Han, et al.
Publicado: (2017)

Methotrexate/prednisone/rituximab: COVID-19 pneumonia: 3 case reports
Publicado: (2021)

Methotrexate/prednisolone/rituximab: COVID-19 pneumonia: 2 case reports
Publicado: (2021)

Cytarabine/dasatinib/rituximab: Reactivation of COVID-19 pneumonia : case report
Publicado: (2020)

Rituximab: Relapse or exacerbation of COVID-19 pneumonia: 4 case reports
Publicado: (2022)

Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report()
por: Arai, Tatsuya, et al.
Publicado: (2022)

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
por: Bega, Giulia, et al.
Publicado: (2021)

Bendamustine/remdesivir/rituximab: Emergence of drug resistance and SARS-CoV-2 viraemia due to B-cell immunodeficiency : case report
Publicado: (2021)

Rituximab: COVID-19 pneumonia and herpes simplex virus infection: case report
Publicado: (2022)

Rituximab: COVID‐19 infection complicated by secondary organising pneumonia: case report
Publicado: (2022)

Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan
por: Lane, Michael A., et al.
Publicado: (2015)

Successful Treatment of Factor X Deficiency in a Patient with Lymphoplasmacytic Lymphoma with Bendamustine Plus Rituximab Regimen: A Case Report and Literature Review
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2021)

Prednisolone/rituximab: COVID-19 and SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Obinutuzumab/rituximab: Decreased platelet count and chronic COVID-19 pneumonia: case report
Publicado: (2020)

Rituximab: COVID-19: case report
Publicado: (2021)

Rituximab: COVID-19: case report
Publicado: (2022)

Rituximab: COVID-19: case report
Publicado: (2022)

Methotrexate/rituximab/tozinameran interaction: Brain death secondary to the COVID-19 pneumonia: case report
Publicado: (2021)

Bendamustine-induced nephrogenic diabetes insipidus – A case report
por: Desjardins, Audrey, et al.
Publicado: (2021)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
por: Rai, Shinya, et al.
Publicado: (2018)

Rituximab: COVID-19: 2 case reports
Publicado: (2021)

Rituximab: COVID-19: 2 case report
Publicado: (2021)

Prednisone/rituximab: COVID-19: case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kk1f75ot7db764m848bn8mmvrj